Trade with Eva: Analytics in action >>
Showing posts with label APVO. Show all posts
Showing posts with label APVO. Show all posts

Thursday, March 7, 2019

Aptevo Therapeutics (APVO) : pricing of equity offering



 







Aptevo Therapeutics (APVO) slumps on almost 13x higher volume in response to its public offering of 19.85M shares of common stock and warrants to purchase up to the same number of shares at a price of $1.00 per share and warrant.
  • The company is also offering pre-funded warrants to purchase up to 2.15M common shares at $0.01 per share and related warrants to purchase up to 2.15M common shares at $1.30 at a combined price of $0.99.
  • Total gross proceeds should be ~$22.00M. Closing date is March 11.
  • Yesterday's close was $1.48.

Thursday, October 5, 2017

Aptevo Therapeutics (APVO) : Piper Jaffray initiates coverage

Piper Jaffray initiated coverage Aptevo Therapeutics. Price target $6, overweight rating.



** charts day before earnings **